To overcome this paradox, several findings were initially proposed by the concept of pathway-selective hepatic insulin resistance, supporting a dichotomic dysregulation of insulin signaling through the inhibition of the Akt/FoxO1 and the maintenance of the SREBP1c biological activity [17,18]. This evidence concerns the gene INS and Insulin resistance.